Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials


Parallel Effects of Ketamine and Schizophrenia on Neurocognitive Function


To see complete record on clinicaltrials.gov, please visit this link

Id: NCT02675530

Organisation Name: Yale University

Overal Status: Completed

Start Date: December 2007

Last Update: February 5, 2016

Lead Sponsor: Yale University

Brief Summary: This study investigates the common features of electrophysiological measures in schizophrenia and effects of NMDA antagonist ketamine in healthy volunteers.

Conditions:
  • Schizophrenia


Total execution time in seconds: 0.4342098236084